Biocompatibles, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.4Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
2,272clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Riad Salem | Chicago, IL | Vascular & Interventional Radiology | $151,473.73 |
| Steven Elias | Englewood, NJ | Vascular Surgery | $106,636.14 |
| Robert Lewandowski | Chicago, IL | Vascular & Interventional Radiology | $62,242.96 |
| Amjad Alkadri | Valparaiso, IN | Vascular & Interventional Radiology | $50,818.57 |
| Michael Shao | Fort Wayne, IN | Vascular Surgery | $47,039.13 |
| Pavan Khanna | Stockton, CA | Diagnostic Radiology | $41,941.87 |
| Siddharth Padia | Los Angeles, CA | Vascular & Interventional Radiology | $40,282.29 |
| Edward Kim | New York, NY | Vascular & Interventional Radiology | $27,222.14 |
| Talia Baker | Chicago, IL | Transplant Surgery | $26,887.73 |
| Scott Resnick | Chicago, IL | Vascular & Interventional Radiology | $26,668.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.